| Target Price | $30.60 |
| Price | $13.51 |
| Potential |
126.50%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target MediWound Ltd. 2027 .
The average MediWound Ltd. target price is $30.60.
This is
126.50%
register free of charge
$37.80
179.79%
register free of charge
$22.22
64.47%
register free of charge
|
|
| A rating was issued by 12 analysts: 11 Analysts recommend MediWound Ltd. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the MediWound Ltd. stock has an average upside potential 2027 of
126.50%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 16.96 | 24.15 |
| 16.12% | 42.39% | |
| EBITDA Margin | -142.39% | -132.95% |
| 55.21% | 6.63% | |
| Net Margin | -140.80% | -119.51% |
| 5.79% | 15.12% |
8 Analysts have issued a sales forecast MediWound Ltd. 2026 . The average MediWound Ltd. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an MediWound Ltd. EBITDA forecast 2026. The average MediWound Ltd. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 MediWound Ltd. Analysts have issued a net profit forecast 2026. The average MediWound Ltd. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.10 | -2.24 |
| 30.69% | 6.67% | |
| P/E | negative | |
| EV/Sales | 6.12 |
8 Analysts have issued a MediWound Ltd. forecast for earnings per share. The average MediWound Ltd. EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Oppenheimer |
Locked
➜
Locked
|
Locked | Aug 14 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 28 2026 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | May 28 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 21 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 22 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 20 2025 |
| Craig-Hallum |
Locked
➜
Locked
|
Locked | Feb 28 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Aug 14 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 28 2026 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
May 28 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 21 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 22 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 20 2025 |
|
Locked
Craig-Hallum:
Locked
➜
Locked
|
Feb 28 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


